Research output per year
Research output per year
Personal profile
Research interests
Cold agglutinin disease, complement inhibition, orphan drugs, expensive drugs
Research interests
Kathelijn is an MD currently pursuing a PhD in Hematology at Amsterdam UMC. She is committed to advancing knowledge, exploring innovative solutions, and contributing to impactful research that benefits patients and the medical community.
Fingerprint
Dive into the research topics where Kathelijn Verdeyen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Medicine Development and Access for Rare Diseases: Can We Do Better?
Hollak, C. E. M., Rosenberg, N., Post, C., Stolwijk, N., Manders, E., Schoenmakers, D., Penninx, B., Reijnhout, N., Verdeyen, K., Jonker, R., Bosch, A. M., Langeveld, M., van der Wel, V., de Visser, S. & van den Berg, S., Mar 2026, In: Journal of inherited metabolic disease. 49, 2, p. e70146 e70146.Research output: Contribution to journal › Review article › Academic › peer-review
Open Access -
New opportunities for accessing promising non-oncological orphan drugs
Hollak, C. E. M., Reparon-Schuijt, C. C., Verdeyen, K., Deesker, L. J., Groothoff, J. W., Vos, J. M. I., Huisman, A. H., van der Flier, S. & Pisters-van Roy, A. A. M. G., 1 May 2025, In: The Lancet Regional Health - Europe. 52, p. 101275 101275.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile45 Downloads (Pure) -
Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia
Verdeyen, K., Reuvekamp, T., Van der Velden, W. J. F. M., Wouters, B. J., Von dem Borne, P. A., Van Rhenen, A., Lissenberg-Witte, B. I., Van Lammeren, D., Van Sluis, G. L., De Jongh, E., Fiets, R. B., Corsten, M. F., Van der Spek, A. C., Gerrits, A. M., Van Bladel, E. R., Tick, L. W., De Weerdt, O., Van Zaane, B., Cruijsen, M. J. & Posthuma, E. F. M. & 4 others, , 18 Sept 2025, (E-pub ahead of print) In: Haematologica.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
Het ‘Orphan Drug Access Protocol’ voor sutimlimab: innovatieve werkwijze om behandeling met nieuwe complementremmer voor koude-agglutinatieziekte mogelijk te maken
Translated title of the contribution :Orphan Drug Access Protocol for sutimlimab: innovative approach to enable treatment with new complement inhibitor for cold agglutinin disease Research output: Contribution to journal › Article › Professional
Activities
- 1 Oral presentation
-
Oral Presentation
Verdeyen, K. (Speaker)
14 Jun 2024Activity: Talk or presentation › Oral presentation › Academic